Research Topics
| Tait ShanafeltSummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemiaKami Maddocks Christianson
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Br J Haematol 139:398-404. 2007..Physicians should strictly adhere to established criteria to initiate treatment for CLL patients who are not participating in clinical trials...
Overall and Cancer-Specific Survival of Patients With Breast, Colon, Kidney, and Lung Cancers With and Without Chronic Lymphocytic Leukemia: A SEER Population-Based StudyBenjamin M Solomon
Mayo Clinic, 200 First St SW, Rochester, MN 55905
J Clin Oncol 31:930-7. 2013..Additional studies are needed to determine the optimal management of these malignancies in patients with CLL and whether more aggressive screening or alternative approaches to adjuvant therapy are needed...
Burnout and satisfaction with work-life balance among US physicians relative to the general US populationTait D Shanafelt
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
Arch Intern Med 172:1377-85. 2012..Despite extensive data about physician burnout, to our knowledge, no national study has evaluated rates of burnout among US physicians, explored differences by specialty, or compared physicians with US workers in other fields...
Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemiaTait D Shanafelt
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 119:363-70. 2013..The objective of the current study was to follow up the results of phase 1 testing by evaluating the clinical efficacy of the green tea extract Polyphenon E for patients with early stage chronic lymphocytic leukemia (CLL)...
Improving treatment for patients with chronic lymphocytic leukemiaTait D Shanafelt
Hematology 17:S133-6. 2012..In this mini-review, we summarize Mayo Clinic's recent efforts to improve CIT for patients with CLL...
Avoiding burnout: the personal health habits and wellness practices of US surgeonsTait D Shanafelt
Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA
Ann Surg 255:625-33. 2012..To evaluate the health habits, routine medical care practices, and personal wellness strategies of American surgeons and explore associations with burnout and quality of life (QOL)...
Oncologist burnout: causes, consequences, and responsesTait Shanafelt
Mayo Clinic, Rochester, MN 55905, USA
J Clin Oncol 30:1235-41. 2012..In this review, we examine the causes, consequences, and personal ramifications of oncologist burnout and explore the steps oncologists can take to promote personal well-being and professional satisfaction...
Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)Tait D Shanafelt
Mayo Clinic, Rochester, Minnesota 55902, USA
Cancer 118:1827-37. 2012....
The influence of personal and environmental factors on professionalism in medical educationColin P West
Division of General Internal Medicine, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA
BMC Med Educ 7:29. 2007..An understanding of the factors contributing to professionalism may allow the development of more effective approaches to promoting this quality in medical education...
Development and preliminary psychometric properties of a well-being index for medical studentsLiselotte N Dyrbye
Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
BMC Med Educ 10:8. 2010....
T-cell abnormalities in patients with chronic lymphocytic leukemiaTait Shanafelt
Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Rochester, MN 55905, USA
Leuk Lymphoma 47:1197-8. 2006
Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical managementT D Shanafelt
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA
Leukemia 24:512-20. 2010..In this paper, we provide a state of the art review on the prevalence, nomenclature, biology, natural history and clinical management of MBL...
CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potentialTait D Shanafelt
Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Br J Haematol 140:537-46. 2008..Importantly, anti-CD49d antibodies are already approved for treatment of other human diseases. Clinical testing of anti-CD49d therapy in CLL appears warranted...
Burnout and medical errors among American surgeonsTait D Shanafelt
Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
Ann Surg 251:995-1000. 2010..To evaluate the relationship between burnout and perceived major medical errors among American surgeons...
Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemiaTait D Shanafelt
Mayo Clinic, Rochester, MN 55905, USA
J Clin Oncol 27:3959-63. 2009..The natural history of clinically identified MBL is unclear. The goal of this study was to explore the outcome of patients with MBL relative to that of individuals with Rai stage 0 chronic lymphocytic leukemia (CLL)...
Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemiaTait D Shanafelt
Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Br J Haematol 146:660-4. 2009..The pretreatment VEGF:TSP ratio also correlated with overall survival (P = 0.008). A pro-angiogenic profile appears associated with diminished response and inferior survival in CLL patients receiving CIT...
The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemiaTait D Shanafelt
Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, United States
Leuk Res 33:263-70. 2009..The effectiveness with which physicians help patients adjust to the physical, intellectual, and emotional challenges of CLL appears to impact patient QOL...
Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patientsTait D Shanafelt
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Br J Haematol 139:255-64. 2007..The effects of CLL on QOL appear to differ from that of other malignancies with a more marked impact on emotional QOL. Research identifying efficacious psycho-oncologic support interventions for patients with CLL is needed...
Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemiaTait D Shanafelt
Department of Internal Medicine, Division of Hematology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Cancer 109:2291-8. 2007..Although chemoimmunotherapy (CIT) has dramatically improved response rates in patients with CLL, some CIT regimens are not well tolerated by many patients >or=70 years of age...
B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcomeTait D Shanafelt
Mayo Clinic, Rochester, MN, USA
Blood 113:4188-96. 2009..Using clinically relevant criteria to distinguish between monoclonal B-cell lymphocytosis (MBL) and CLL could minimize patient distress caused by labeling asymptomatic people at low risk for adverse clinical consequences as having CLL...
Validation of a new prognostic index for patients with chronic lymphocytic leukemiaTait D Shanafelt
Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 115:363-72. 2009..This index requires validation in an independent series of patients before widespread use can be recommended...
Monoclonal B-cell lymphocytosis: definitions and natural historyTait Shanafelt
Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
Leuk Lymphoma 50:493-7. 2009..Additional studies are needed to determine whether the clinical outcome of patients with MBL differs from that of patients with Rai stage 0 CLL and to identify what B-cell threshold optimally distinguishes between these conditions...
Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemiaTait D Shanafelt
Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
J Clin Oncol 27:3808-14. 2009..To define the optimal dose of Polyphenon E for chronic daily administration and tolerability in patients with chronic lymphocytic leukemia (CLL)...
Special report: suicidal ideation among American surgeonsTait D Shanafelt
Mayo Clinic, Rochester, MN 55905, USA
Arch Surg 146:54-62. 2011..Suicide is a disproportionate cause of death for US physicians. The prevalence of suicidal ideation (SI) among surgeons and their use of mental health resources are unknown...
Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemiaTait D Shanafelt
Division of Hematology, Mayo Clinic, Rochester, MN, USA
Leuk Lymphoma 51:1233-40. 2010..The in vitro observation that statins reduce rituximab efficacy does not appear to have clinical significance in CLL care...
Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemiaTait D Shanafelt
Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, Minnesota 55902, USA
Cancer 116:4777-87. 2010..A study was undertaken to analyze the survival of chronic lymphocytic leukemia (CLL) patients relative to age-matched individuals in the general population and determine the age-stratified utility of prognostic testing...
The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemiaTait D Shanafelt
Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Semin Oncol 33:174-85. 2006....
Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndromeTait D Shanafelt
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
Mayo Clin Proc 78:1340-6. 2003..To evaluate the efficacy of rituximab for the treatment of adult patients with immune cytopenia, including idiopathic thrombocytopenic purpura (ITP), autoimmune hemolytic anemia, and Evans syndrome...
Shaping your career to maximize personal satisfaction in the practice of oncologyTait Shanafelt
Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Rochester, MN, USA
J Clin Oncol 24:4020-6. 2006....
Current approach to diagnosis and management of chronic lymphocytic leukemiaTait D Shanafelt
Division of Hematology and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
Mayo Clin Proc 79:388-98. 2004....
Are chemotherapy response rates related to treatment-induced survival prolongations in patients with advanced cancer?Tait D Shanafelt
Departmentof Ocology, Mayo Clinic, Rochester, MN 55905, USA
J Clin Oncol 22:1966-74. 2004..The average prolongation in survival with chemotherapy compared with best supportive care has not been well described...
Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabineTait D Shanafelt
Department of Medicine, Division of Hematology, Mayo Clinic, 200 First St, SW, Rochester, MN 55905, USA
Blood 105:2099-106. 2005..Further preclinical development of adaphostin as a novel agent for the treatment of CLL appears warranted...
A career in surgical oncology: finding meaning, balance, and personal satisfactionTait Shanafelt
Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Ann Surg Oncol 15:400-6. 2008..In this article, we review the literature on surgeon burnout, discuss potential personal and professional consequences, and consider steps individual surgeons can take to promote personal and professional satisfaction...
The well-being and personal wellness promotion strategies of medical oncologists in the North Central Cancer Treatment GroupTait D Shanafelt
Department of Oncology, Mayo Clinic, Rochester, Minn, USA
Oncology 68:23-32. 2005..While much is known about oncologist distress, little is known about oncologist well-being. We set out to evaluate oncologist well-being and the personal wellness promotion strategies used by oncologists...
Finding meaning, balance, and personal satisfaction in the practice of oncologyTait D Shanafelt
Mayo Clinic, Departments of Oncology and Hematology/Oncology, Rochester, Minnesota 55905, USA
J Support Oncol 3:157-62, 164. 2005
Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemiaTait Shanafelt
Department of Medicine, Mayo Clinic, Rochester, MN 55902, USA
Leuk Lymphoma 51:2222-9. 2010..No complete or partial remissions were observed. Individually and collectively, these studies indicate that single-agent anti-VEGF therapy has minimal clinical activity for patients with relapsed/refractory CLL...
Pathophysiology and treatment of hot flashesTait D Shanafelt
Department of Oncology, Mayo Clinic, Rochester, Minn 55905, USA
Mayo Clin Proc 77:1207-18. 2002..The use of clonidine, methyldopa, and belladonna should be discouraged because of their modest efficacy and adverse effects...
Clinical effects of oral green tea extracts in four patients with low grade B-cell malignanciesT D Shanafelt
Mayo Clinic College of Medicine, Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Leuk Res 30:707-12. 2006..An NCI sponsored phase I/II trial of de-caffeinated green tea extracts for patients with asymptomatic, early stage CLL opened at Mayo Clinic in August 2005...
Relationship between increased personal well-being and enhanced empathy among internal medicine residentsTait D Shanafelt
Department of Internal Medicine, Mayo Clinic, Rochester, Minn, USA
J Gen Intern Med 20:559-64. 2005..While resident distress and its potential to negatively effect patient care have been well documented, little is known bout resident well-being or its potential to enhance care...
Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemiaPaul Thurmes
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Leuk Lymphoma 49:49-56. 2008..Clinical trials evaluating treatments that are designed to be tolerated by patients who do not meet traditional clinical trial eligibility criteria are needed...
Pilot evaluation of citalopram for the relief of hot flashesDebra L Barton
Mayo Clinic, Rochester, Minnesota 55905, USA
J Support Oncol 1:47-51. 2003..This pilot trial suggests that citalopram may be an effective non-hormonal treatment for hot flashes in women who can tolerate it...
Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disordersAnne J Novak
Division of Hematology and Internal Medicine, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
J Clin Oncol 24:983-7. 2006..6-fold increase in activity (P = .004). CONCLUSION: Our data suggest serum BLyS levels are elevated in patients with familial B-CLL and that elevated BLyS levels correlate with the presence of a T at -871 in the BLyS promoter...
Phase II Evaluation of Desipramine for the Treatment of Hot FlashesDebra L Barton
Comprehensive Cancer Center, Mayo Clinic College of Medicine, Rochester, MN
Support Cancer Ther 4:219-24. 2007..It is of physiologic interest that this older antidepressant, classified as a tricyclic, did not achieve a clinically significant reduction in hot flash scores in this pilot trial...
Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemiaWilliam Martin
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA
Transl Res 149:231-5. 2007..Future studies are warranted to elucidate the role of serum FLC as biomarkers of disease, for monitoring of minimal residual disease, and as a prognostic factor for response and survival...
When your favorite patient relapses: physician grief and well-being in the practice of oncologyTait Shanafelt
Department of Oncology, Mayo Clinic, Rochester, MN, USA
J Clin Oncol 21:2616-9. 2003
VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistanceY K Lee
Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
Leukemia 19:513-23. 2005..Thus, a VEGF-VEGF receptor pathway in CLL B cells can be linked to activation of STAT proteins that are able to enhance their apoptotic resistance...
Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximabClive S Zent
Division of Hematology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 113:2110-8. 2008..In this phase 2 study, the authors tested the safety and efficacy of early treatment for patients with high-risk CLL using alemtuzumab and rituximab...
Road map for maintaining career satisfaction and balance in surgical oncologyHenry M Kuerer
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
J Am Coll Surg 207:435-42. 2008
Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemiaStephanie R Fink
Division of Laboratory Genetics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Leuk Res 29:253-62. 2005..Deletions in IGHv occurred in 25% of patients and correlated with IGHv gene expression. Probes for 6q23 detected more deletions in 6q than probes for 6q21...
The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphomaClive S Zent
Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
Br J Haematol 141:615-21. 2008..Revisions of the National Cancer Institute Working Group 96 criteria should consider the aetiology of cytopenia in staging CLL patients...
Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemiaShanique Palmer
Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Br J Haematol 141:607-14. 2008..These characteristics can be modified and continued evaluation of immunomodulatory drugs, vaccination strategies and cellular therapies to delay/prevent disease progression are warranted...
Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expressionTait D Shanafelt
J Clin Oncol 26:e5-6. 2008
Effects of resident work hour limitations on faculty professional livesLara Goitein
Department of Radiology, University of Washington Medical Center, Seattle, WA, USA
J Gen Intern Med 23:1077-83. 2008..The Accreditation Council for Graduate Medical Education resident work hour limitations were implemented in July, 2003. Effects on faculty are not well understood...
Burnout and suicidal ideation among U.S. medical studentsLiselotte N Dyrbye
Mayo Clinic, Rochester, Minnesota, USA
Ann Intern Med 149:334-41. 2008..Little is known about the prevalence of suicidal ideation among U.S. medical students or how it relates to burnout...
Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patientsWilliam G Morice
Division of Hematopathology, Mayo Clinic, Rochester, MN 55905, USA
Mayo Clin Proc 83:776-85. 2008..To study the effectiveness of peripheral blood (PB) and bone marrow flow cytometric immunophenotyping (FCIP) in predicting the histologic B-cell lymphoma type...
Controversies in the front-line management of chronic lymphocytic leukemiaChadi Nabhan
Oncology Specialists, S C, Lutheran General Hospital, Department of Medicine, Division of Hematology and Medical Oncology, Park Ridge, IL 60068, USA
Leuk Res 32:679-88. 2008..The review is intended to discuss and simplify first-line therapy selection for patients with CLL in the era of new prognostic indicators and the better understanding of disease biology...
MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?Tait D Shanafelt
Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, United States
Leuk Res 32:1458-61. 2008..In contrast, CD38 predicted TTT (p=0.02) regardless of the proposed new classification. Molecular characteristics of the leukemic clone are a better predictor of progression than an arbitrary ALC or B lymphocyte count threshold...
Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch"Neil E Kay
Mayo Clinic, Stabile 628, 200 First Street SW, Rochester, MN 55905, USA
Leuk Res 31:899-906. 2007..These results indicate the interaction between CLL B-cells and marrow stromal elements regulates angiogenic switching and may be linked to disease progression...
A multicenter study of burnout, depression, and quality of life in minority and nonminority US medical studentsLiselotte N Dyrbye
Division of Primary Care Internal Medicine, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 81:1435-42. 2006..To determine the well-being of minority medical students in a multicenter sample of US medical students...
Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemiaNeil E Kay
Mayo Clinic, Stabile 628, 200 First St SW, Rochester, MN 55905, and The Ohio State University, Columbus, USA
Blood 109:405-11. 2007....
Association of perceived medical errors with resident distress and empathy: a prospective longitudinal studyColin P West
Division of General Internal Medicine, Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
JAMA 296:1071-8. 2006..Medical errors are associated with feelings of distress in physicians, but little is known about the magnitude and direction of these associations...
Personal life events and medical student burnout: a multicenter studyLiselotte N Dyrbye
Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55906, USA
Acad Med 81:374-84. 2006..The authors sought to identify the prevalence of burnout, variation of its prevalence during medical school, and the impact of personal life events on burnout and other types of student distress...
Systematic review of depression, anxiety, and other indicators of psychological distress among U.S. and Canadian medical studentsLiselotte N Dyrbye
Mayo Clinic, 200 First Street SW, Rochester, MN 55906, USA
Acad Med 81:354-73. 2006..To systematically review articles reporting on depression, anxiety, and burnout among U.S. and Canadian medical students...
The effects of work-hour limitations on resident well-being, patient care, and education in an internal medicine residency programLara Goitein
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Box 359762, University of Washington Harborview Medical Center, 325 Ninth Avenue, Seattle, WA 98104, USA
Arch Intern Med 165:2601-6. 2005..Overall, most residents (65%) approved of WHLs. CONCLUSIONS: Internal medicine residents approve of WHLs overall and report benefits to their well-being. However, they also report negative effects on patient care and resident education...
Medical student distress: causes, consequences, and proposed solutionsLiselotte N Dyrbye
Department of Internal Medicine and Division of Primary Care Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
Mayo Clin Proc 80:1613-22. 2005..In this article, we review the manifestations and causes of student distress, its potential adverse personal and professional consequences, and proposed institutional approaches to decrease student distress...
Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxineCharles L Loprinzi
Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
J Palliat Med 8:924-30. 2005....
VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemiaYean K Lee
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA
Blood 104:788-94. 2004..Thus, these results suggest that VEGF signaling regulates survival signals in CLL cells and that interruption of this autocrine pathway results in caspase activation and subsequent leukemic cell death...
The well-being of physiciansTait D Shanafelt
Mayo Clinic, Rochester, Minnesota, USA
Am J Med 114:513-9. 2003
How do distress and well-being relate to medical student empathy? A multicenter studyMatthew R Thomas
Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
J Gen Intern Med 22:177-83. 2007....
Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic testGrzegorz S Nowakowski
Division of Hematology, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 82:449-53. 2007..001). The percentage of smudge cells as a continuous variable correlated with overall survival (P=.04). The estimation of smudge cells on a blood smear could be a universally available prognostic test in early-stage CLL...
A prospective study of the relationship between medical knowledge and professionalism among internal medicine residentsColin P West
Division of General Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55095, USA
Acad Med 82:587-92. 2007..To explore residents' competency in medical knowledge and in empathy, one element of professionalism, and to evaluate the relationship between competencies in these domains...
Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic featuresDeborah A Bowen
Mayo Clinic College of Medicine, Rochester, Minnesota 55902, USA
Leuk Lymphoma 48:2412-7. 2007..Three-year survival was 41% (95% CI: 26 - 66%). HDMP-rituximab is an active regimen in patients with relapsed, refractory, and cytogenetically high-risk CLL. Further evaluation of this regimen in controlled trials appears warranted...
Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patientsRenee C Tschumper
Department of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
J Clin Invest 118:306-15. 2008..In addition, these data support the concept that antigen-driven selection of specific Ig receptors plays a role in the clinical course of B-CLL...
Community-based phase II trial of PCR for CLL/SLL patientsNeil E Kay
Cancer Biother Radiopharm 22:713-4; author reply 715-7. 2007
Race, ethnicity, and medical student well-being in the United StatesLiselotte N Dyrbye
Department of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55906, USA
Arch Intern Med 167:2103-9. 2007..We explore differences in the prevalence of burnout, depressive symptoms, and quality of life (QOL) among minority and nonminority medical students as well as the role race/ethnicity plays in students' experiences...
Physician well-being and professionalismColin P West
Mayo Clinic College of Medicine, USA
Minn Med 90:44-6. 2007....
Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical OncologyHenry M Kuerer
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Ann Surg Oncol 14:3043-53. 2007..Studies show that 30-50% of medical oncologists experience burnout, but little is known about burnout among surgical oncologists. We hypothesized that wide variation in burnout and career satisfaction exist among surgical oncologists...
Burnout and self-reported patient care in an internal medicine residency programTait D Shanafelt
University of Washington, Veterans Affairs Northwest Health Services Research and Development Center of Excellence, and Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108, USA
Ann Intern Med 136:358-67. 2002..CONCLUSION: Burnout was common among resident physicians and was associated with self-reported suboptimal patient care practices...
Medical education research and IRB review: an analysis and comparison of the IRB review process at six institutionsLiselotte N Dyrbye
Mayo Clinic Department of Internal Medicine, Rochester, Minnesota, USA
Acad Med 82:654-60. 2007..To compare how different institutional review boards (IRBs) process and evaluate the same multiinstitutional educational research proposal of medical students' quality of life...
Update on risk-stratified management for chronic lymphocytic leukemiaClive S Zent
Division of Hematology, Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN 55905, USA
Leuk Lymphoma 47:1738-46. 2006..The management of CLL is in a dynamic phase of rapid evolution. Risk stratification using biological prognostic markers can improve current patient care and direct future clinical research...
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemiaRebekah L Browning
Ohio State University, Columbus, OH, United States
Leuk Res 31:1737-40. 2007..199) were noted with lower TCL-1 expression. These data suggest TCL-1 expression may help predict treatment outcome in CLL patients following chemoimmunotherapy, and examination in larger studies is warranted...
Combination therapies for previously untreated CLLTait D Shanafelt
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Lancet 370:197-8. 2007
Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemiaStephanie R Fink
Cytogenetics Laboratory, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Cancer Genet Cytogenet 167:177-81. 2006..Translocations or isochromosome formations at sites of low-copy DNA repeats in 17p10 to 17p12 appear to be the mechanism for the loss of TP53 in B-CLL...
Andropause: symptom management for prostate cancer patients treated with hormonal ablationCarrie A Thompson
Mayo Clinic, Rochester, Minnesota 55905, USA
Oncologist 8:474-87. 2003..In this article, we review the current literature on the symptoms, signs, and possible therapies available to men who cannot take replacement testosterone...
Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemiaTait D Shanafelt
Mayo Clinic College of Medicine, Department of Internal Medicine, Division of Hematology, Rochester, MN 55905, USA
J Clin Oncol 24:4634-41. 2006..These findings have important implications for both clinical management and trials of early treatment for patients with high-risk, early-stage CLL...
Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemiaTait D Shanafelt
Department of Internal Medicine, Division of Hematology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Ann Intern Med 145:435-47. 2006..Recommendations for patient counseling, follow-up, supportive care, and initial treatment are presented for each risk category...
Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemiaTait D Shanafelt
J Clin Oncol 24:3218-9; author reply 3219-20. 2006
Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemiaKimberly J Stockero
Cytogenetics Laboratory, Mayo Clinic, Rochester, MN 55905, USA
Cancer Genet Cytogenet 166:152-6. 2006..As a result of this study, we report evidence that B-CLL metaphases with 13q- are not detected because these deletions are often cryptic and not visible by standard G-banding...
